Home
VRTX
VRTX News

Latest Vertex Pharmaceuticals Incorporated (VRTX) News on September 13, 2025

Vertex Scientists Awarded the 2025 Lasker~DeBakey Clinical Medical Research Award for Pioneering Discoveries in Cystic Fibrosis

Business Wire

2 days ago

Vertex Scientists Awarded the 2025 Lasker~DeBakey Clinical Medical Research Award for Pioneering Discoveries in Cystic Fibrosis

MT Newswires

2 days ago

Evercore ISI Adjusts PT on Vertex Pharmaceuticals to $475 From $510, Maintains Outperform Rating

Vertex Pharmaceuticals (VRTX) Stock Slides as Market Rises: Facts to Know Before You Trade

Zacks

3 days ago

Vertex Pharmaceuticals (VRTX) Stock Slides as Market Rises: Facts to Know Before You Trade

US Cystic Fibrosis Therapeutics Market Forecast and Company Analysis Report 2025-2033 Featuring Vertex, Abbvie, Novartis, Gilead Sciences, Viatris, Pfizer, AstraZeneca, and F. Hoffmann-La Roche

GlobeNewswire

3 days ago

US Cystic Fibrosis Therapeutics Market Forecast and Company Analysis Report 2025-2033 Featuring Vertex, Abbvie, Novartis, Gilead Sciences, Viatris, Pfizer, AstraZeneca, and F. Hoffmann-La Roche

Is Vertex Pharmaceuticals Stock Underperforming the S&P 500?

Barchart

5 days ago

Is Vertex Pharmaceuticals Stock Underperforming the S&P 500?

Why This Biotech Company Could Be a Growth Stock Powerhouse

Motley Fool

9 days ago

Why This Biotech Company Could Be a Growth Stock Powerhouse

Why Is Vertex (VRTX) Up 6.9% Since Last Earnings Report?

Zacks

10 days ago

Why Is Vertex (VRTX) Up 6.9% Since Last Earnings Report?

Here’s Why Vertex Pharmaceuticals (VRTX) is on Loomis Sayles Growth Fund’s Detractors List

Insider Monkey

10 days ago

Here’s Why Vertex Pharmaceuticals (VRTX) is on Loomis Sayles Growth Fund’s Detractors List

Vertex Pharmaceuticals Incorporated (VRTX) Slid on Softer Revenue and Earnings

Insider Monkey

11 days ago

Vertex Pharmaceuticals Incorporated (VRTX) Slid on Softer Revenue and Earnings

Enlaza Therapeutics Announces Strategic Collaboration with Vertex Pharmaceuticals to Develop War-Lock Drug Conjugates and T-Cell Engagers for Improved Conditioning and Certain Autoimmune Diseases

Business Wire

11 days ago

Enlaza Therapeutics Announces Strategic Collaboration with Vertex Pharmaceuticals to Develop War-Lock Drug Conjugates and T-Cell Engagers for Improved Conditioning and Certain Autoimmune Diseases

Vertex Pharmaceuticals Incorporated's (NASDAQ:VRTX) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?

Simply Wall St.

12 days ago

Vertex Pharmaceuticals Incorporated's (NASDAQ:VRTX) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?

August jobs report due out as Fed uncertainty looms: What to watch this week

Yahoo Finance

13 days ago

August jobs report due out as Fed uncertainty looms: What to watch this week

Large-cap biotech is a sector to watch for investors: Analysts

Yahoo Finance

13 days ago

Large-cap biotech is a sector to watch for investors: Analysts

3 No-Brainer Stocks to Buy Right Now

Motley Fool

13 days ago

3 No-Brainer Stocks to Buy Right Now

Can CRSP's In Vivo Pipeline Aid Long-Term Growth Beyond Casgevy?

Zacks

15 days ago

Can CRSP's In Vivo Pipeline Aid Long-Term Growth Beyond Casgevy?

MT Newswires

15 days ago

DBS Bank Adjusts Price Target on Vertex Pharmaceuticals to $480 From $600, Maintains Buy Rating

CRSP vs. BEAM: Which Gene Editing Stock Holds More Potential Right Now?

Zacks

16 days ago

CRSP vs. BEAM: Which Gene Editing Stock Holds More Potential Right Now?

National Advertising Division Refers Maze Therapeutics to Regulatory Authorities for Failure to Respond to Inquiry

GlobeNewswire

17 days ago

National Advertising Division Refers Maze Therapeutics to Regulatory Authorities for Failure to Respond to Inquiry

Vertex Pharmaceuticals Incorporated (VRTX) is Attracting Investor Attention: Here is What You Should Know

Zacks

17 days ago

Vertex Pharmaceuticals Incorporated (VRTX) is Attracting Investor Attention: Here is What You Should Know

Vortex Energy Initiates Sensor Recollection at Robinsons River Salt Project Following Completion of ANT Data Collection Phase

GlobeNewswire

18 days ago

Vortex Energy Initiates Sensor Recollection at Robinsons River Salt Project Following Completion of ANT Data Collection Phase

Do Wall Street Analysts Like Vertex Pharmaceuticals Stock?

Barchart

20 days ago

Do Wall Street Analysts Like Vertex Pharmaceuticals Stock?

This Magnificent S&P 500 Dividend Stock Is Down 18% -- Time to Buy?

Motley Fool

20 days ago

This Magnificent S&P 500 Dividend Stock Is Down 18% -- Time to Buy?

Strong Product Launches and Upbeat Guidance Could Be a Game Changer for Vertex Pharmaceuticals (VRTX)

Simply Wall St.

22 days ago

Strong Product Launches and Upbeat Guidance Could Be a Game Changer for Vertex Pharmaceuticals (VRTX)

MT Newswires

23 days ago

Argus Cuts Price Target on Vertex Pharmaceuticals to $475 From $525

Argus Research

23 days ago

Market Update: ADI, ITW, LOW, GEN, VRTX, HLN

Argus Research

23 days ago

Analyst Report: Vertex Pharmaceuticals, Inc.

CRISPR Therapeutics Gains 41.4% in 3 Months: How to Play the Stock

Zacks

23 days ago

CRISPR Therapeutics Gains 41.4% in 3 Months: How to Play the Stock

Why investors should buy Amphenol & avoid Vertex Pharmaceuticals

Yahoo Finance Video

23 days ago

Why investors should buy Amphenol & avoid Vertex Pharmaceuticals

Vertex to Participate in Upcoming September Investor Conferences

Business Wire

24 days ago

Vertex to Participate in Upcoming September Investor Conferences

MT Newswires

24 days ago

Rothschild & Co Redburn Adjusts PT on Vertex Pharmaceuticals to $530 From $560, Maintains Buy Rating

What's Wrong With Vertex Pharmaceuticals Stock?

Motley Fool

24 days ago

What's Wrong With Vertex Pharmaceuticals Stock?

Goldman Sachs Reiterated a Buy Rating on Vertex Pharmaceuticals (VRTX), Kept the PT Unchanged

Insider Monkey

a month ago

Goldman Sachs Reiterated a Buy Rating on Vertex Pharmaceuticals (VRTX), Kept the PT Unchanged

3 Fantastic Growth Stocks to Buy in August

Motley Fool

a month ago

3 Fantastic Growth Stocks to Buy in August

Insiders Snap Up These 2 Stocks on the Dip — Here’s Why They Draw Plaudits from Goldman Sachs

TipRanks

a month ago

Insiders Snap Up These 2 Stocks on the Dip — Here’s Why They Draw Plaudits from Goldman Sachs

Vertex Pharma CEO Buys the Stock Dip

Barrons.com

a month ago

Vertex Pharma CEO Buys the Stock Dip

Is This Beaten-Down Stock a Buy on the Dip?

Motley Fool

a month ago

Is This Beaten-Down Stock a Buy on the Dip?

2 Growth Stocks That Are No-Brainer Buys Right Now

Motley Fool

a month ago

2 Growth Stocks That Are No-Brainer Buys Right Now

Vortex Energy Successfully Deploys ANT Sensors at Robinsons River Salt Project

GlobeNewswire

a month ago

Vortex Energy Successfully Deploys ANT Sensors at Robinsons River Salt Project

Vertex Pharmaceuticals Incorporated (VRTX) Is a Trending Stock: Facts to Know Before Betting on It

Zacks

a month ago

Vertex Pharmaceuticals Incorporated (VRTX) Is a Trending Stock: Facts to Know Before Betting on It

[Latest] Global AI in Synthetic Biology Market Size/Share Worth USD 192.95 Billion by 2034 at a 28.63% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)

GlobeNewswire

a month ago

[Latest] Global AI in Synthetic Biology Market Size/Share Worth USD 192.95 Billion by 2034 at a 28.63% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)

MT Newswires

a month ago

Daiwa Securities Adjusts Price Target on Vertex Pharmaceuticals to $430 From $530, Maintains Buy Rating

The 5 Most Interesting Analyst Questions From Vertex Pharmaceuticals’s Q2 Earnings Call

StockStory

a month ago

The 5 Most Interesting Analyst Questions From Vertex Pharmaceuticals’s Q2 Earnings Call

VRTX Q2 2025 Deep Dive: New Product Launches and Pipeline Update in a Volatile Market

StockStory

a month ago

VRTX Q2 2025 Deep Dive: New Product Launches and Pipeline Update in a Volatile Market

Can Rising Casgevy Sales Aid CRISPR Therapeutics Post Q2 Earnings?

Zacks

a month ago

Can Rising Casgevy Sales Aid CRISPR Therapeutics Post Q2 Earnings?

Vertex Pharmaceuticals' (NASDAQ:VRTX) Earnings May Just Be The Starting Point

Simply Wall St.

a month ago

Vertex Pharmaceuticals' (NASDAQ:VRTX) Earnings May Just Be The Starting Point

Vertex Minerals to commence high-grade ore production at Reward gold mine

Mining Technology

a month ago

Vertex Minerals to commence high-grade ore production at Reward gold mine

U.S. Physical Therapy, Inc.'s (NYSE:USPH) Intrinsic Value Is Potentially 91% Above Its Share Price

Simply Wall St.

a month ago

U.S. Physical Therapy, Inc.'s (NYSE:USPH) Intrinsic Value Is Potentially 91% Above Its Share Price

Safety Insurance Group's (NASDAQ:SAFT) Shareholders Will Receive A Bigger Dividend Than Last Year

Simply Wall St.

a month ago

Safety Insurance Group's (NASDAQ:SAFT) Shareholders Will Receive A Bigger Dividend Than Last Year

CDW's (NASDAQ:CDW) Dividend Will Be $0.625

Simply Wall St.

a month ago

CDW's (NASDAQ:CDW) Dividend Will Be $0.625

Canadian Natural Resources Second Quarter 2025 Earnings: EPS Beats Expectations, Revenues Lag

Simply Wall St.

a month ago

Canadian Natural Resources Second Quarter 2025 Earnings: EPS Beats Expectations, Revenues Lag

Citizens Financial Services Second Quarter 2025 Earnings: EPS: US$1.76 (vs US$1.10 in 2Q 2024)

Simply Wall St.

a month ago

Citizens Financial Services Second Quarter 2025 Earnings: EPS: US$1.76 (vs US$1.10 in 2Q 2024)

Pason Systems Second Quarter 2025 Earnings: EPS Misses Expectations

Simply Wall St.

a month ago

Pason Systems Second Quarter 2025 Earnings: EPS Misses Expectations

Institutional investors must be pleased after a 9.8% gain last week that adds to SunOpta Inc.'s (NASDAQ:STKL) one-year returns

Simply Wall St.

a month ago

Institutional investors must be pleased after a 9.8% gain last week that adds to SunOpta Inc.'s (NASDAQ:STKL) one-year returns

Earnings Beat: Saputo Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

Simply Wall St.

a month ago

Earnings Beat: Saputo Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

The Smartest Growth Stocks to Buy With $1,000 Right Now

Motley Fool

a month ago

The Smartest Growth Stocks to Buy With $1,000 Right Now

Argus Research

a month ago

Daily – Vickers Top Buyers & Sellers for 08/08/2025

5 Top Stocks to Buy in August

Motley Fool

a month ago

5 Top Stocks to Buy in August

MT Newswires

a month ago

Vertex Pharmaceuticals Insider Bought Shares Worth $3,895,768, According to a Recent SEC Filing

The RMR Group Announces $1.0 Billion Refinancing of Vertex Pharmaceuticals’ Headquarters in Boston Seaport District

Business Wire

a month ago

The RMR Group Announces $1.0 Billion Refinancing of Vertex Pharmaceuticals’ Headquarters in Boston Seaport District

The Best Stocks to Invest $1,000 In Right Now

Motley Fool

a month ago

The Best Stocks to Invest $1,000 In Right Now

Vertex Pharmaceuticals (VRTX) Reports Strong Q2 2025 Revenue Growth with US$2,965 Million

Simply Wall St.

a month ago

Vertex Pharmaceuticals (VRTX) Reports Strong Q2 2025 Revenue Growth with US$2,965 Million

Morningstar Research

a month ago

Analyst Report: Royalty Pharma plc

Morningstar Research

a month ago

Analyst Report: CRISPR Therapeutics AG

MT Newswires

a month ago

Vertex Pharmaceuticals Shares Rise After Upgrade From Wells Fargo

Vertex Pharmaceuticals (VRTX) Hits New All-Time Low on Failed Clinical Trial

Insider Monkey

a month ago

Vertex Pharmaceuticals (VRTX) Hits New All-Time Low on Failed Clinical Trial

Snap downgraded, Leidos upgraded: Wall Street's top analyst calls

The Fly

a month ago

Snap downgraded, Leidos upgraded: Wall Street's top analyst calls

Vertex Pharmaceuticals Second Quarter 2025 Earnings: Beats Expectations

Simply Wall St.

a month ago

Vertex Pharmaceuticals Second Quarter 2025 Earnings: Beats Expectations

S&P Futures Gain With Focus on Earnings and Fed Speak

Barchart

a month ago

S&P Futures Gain With Focus on Earnings and Fed Speak

MT Newswires

a month ago

Wells Fargo Upgrades Vertex Pharmaceuticals to Overweight From Equalweight, Price Target is $460

Vertex’s Journavx successor culled after falling short in Phase II trial

Clinical Trials Arena

a month ago

Vertex’s Journavx successor culled after falling short in Phase II trial

7 Reasons Why Vertex Pharmaceuticals Is a No-Brainer Stock to Buy on the Dip

Motley Fool

a month ago

7 Reasons Why Vertex Pharmaceuticals Is a No-Brainer Stock to Buy on the Dip

Morningstar Research

a month ago

Analyst Report: Vertex Pharmaceuticals Incorporated

Stocks to Watch Recap: Palantir, Coinbase, Gartner, Pfizer

The Wall Street Journal

a month ago

Stocks to Watch Recap: Palantir, Coinbase, Gartner, Pfizer

These Stocks Moved the Most Today: Palantir, Vertex, Hims & Hers, Coinbase, BP, and More

Barrons.com

a month ago

These Stocks Moved the Most Today: Palantir, Vertex, Hims & Hers, Coinbase, BP, and More

Stock Market Today: Dow Rises Ahead Of Key Data; American Eagle, Coinbase Slide (Live Coverage)

Investor's Business Daily

a month ago

Stock Market Today: Dow Rises Ahead Of Key Data; American Eagle, Coinbase Slide (Live Coverage)

Vertex Pharmaceuticals, Kyndryl, Caterpillar: Trending Tickers

Yahoo Finance Video

a month ago

Vertex Pharmaceuticals, Kyndryl, Caterpillar: Trending Tickers

MT Newswires

a month ago

Canaccord Genuity Adjusts Price Target on Vertex Pharmaceuticals to $411 From $424

Vortex Energy Mobilizes Field Crews for ANT Survey at Robinsons River Salt Project

GlobeNewswire

a month ago

Vortex Energy Mobilizes Field Crews for ANT Survey at Robinsons River Salt Project

MT Newswires

a month ago

HC Wainwright Adjusts Price Target on Vertex Pharmaceuticals to $478 From $550, Maintains Buy Rating

Stocks to Watch Tuesday: Palantir, Hims, Pfizer, Caterpillar

The Wall Street Journal

a month ago

Stocks to Watch Tuesday: Palantir, Hims, Pfizer, Caterpillar

MT Newswires

a month ago

RBC Cuts Price Target on Vertex Pharmaceuticals to $405 From $430, Keeps Sector Perform Rating

5 Things to Know Before the Stock Market Opens

Investopedia

a month ago

5 Things to Know Before the Stock Market Opens

What To Expect From Vertex Pharmaceuticals’s (VRTX) Q2 Earnings

StockStory

a month ago

What To Expect From Vertex Pharmaceuticals’s (VRTX) Q2 Earnings

3 Unstoppable Stocks to Buy in August

Motley Fool

a month ago

3 Unstoppable Stocks to Buy in August

McDonald’s, Palantir, Novo Nordisk Earnings: What to Watch Next Week

The Wall Street Journal

a month ago

McDonald’s, Palantir, Novo Nordisk Earnings: What to Watch Next Week

KBRA Assigns Preliminary Ratings to VRTX 2025-HQ

Business Wire

a month ago

KBRA Assigns Preliminary Ratings to VRTX 2025-HQ

2 Top Stocks I Wouldn't Hesitate to Invest $1,000 in Right Now

Motley Fool

a month ago

2 Top Stocks I Wouldn't Hesitate to Invest $1,000 in Right Now

Stay Ahead of the Game With Vertex (VRTX) Q2 Earnings: Wall Street's Insights on Key Metrics

Zacks

a month ago

Stay Ahead of the Game With Vertex (VRTX) Q2 Earnings: Wall Street's Insights on Key Metrics

Vertex Pharmaceuticals (VRTX) Ascends While Market Falls: Some Facts to Note

Zacks

a month ago

Vertex Pharmaceuticals (VRTX) Ascends While Market Falls: Some Facts to Note

Harmony Biosciences Holdings, Inc. (HRMY) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

Zacks

a month ago

Harmony Biosciences Holdings, Inc. (HRMY) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

Vertex Gears Up to Report Q2 Earnings: Is a Beat in the Cards?

Zacks

a month ago

Vertex Gears Up to Report Q2 Earnings: Is a Beat in the Cards?

Vertex Pharmaceuticals Incorporated (VRTX) is Attracting Investor Attention: Here is What You Should Know

Zacks

a month ago

Vertex Pharmaceuticals Incorporated (VRTX) is Attracting Investor Attention: Here is What You Should Know

LEAD3R Launches 2025 Healthy Team Summit, Sponsored by The Future of Teamwork Podcast

PR Newswire

a month ago

LEAD3R Launches 2025 Healthy Team Summit, Sponsored by The Future of Teamwork Podcast

CRISPR Therapeutics to Report Q2 Earnings: What's in the Cards?

Zacks

2 months ago

CRISPR Therapeutics to Report Q2 Earnings: What's in the Cards?

Vertex Pharmaceuticals (VRTX) Reports Next Week: Wall Street Expects Earnings Growth

Zacks

2 months ago

Vertex Pharmaceuticals (VRTX) Reports Next Week: Wall Street Expects Earnings Growth

The 3 Things That Matter for Vertex Pharmaceuticals Now

Motley Fool

2 months ago

The 3 Things That Matter for Vertex Pharmaceuticals Now

Vertex Pharmaceuticals (VRTX): Buy, Sell, or Hold Post Q1 Earnings?

StockStory

2 months ago

Vertex Pharmaceuticals (VRTX): Buy, Sell, or Hold Post Q1 Earnings?

Vertex Pharmaceuticals Incorporated (VRTX) Launches JOURNAVX, First Non-Opioid Acute Pain Treatment

Insider Monkey

2 months ago

Vertex Pharmaceuticals Incorporated (VRTX) Launches JOURNAVX, First Non-Opioid Acute Pain Treatment

REGN Q2 Earnings: Will Higher Dupixent Profits Fuel Growth?

Zacks

2 months ago

REGN Q2 Earnings: Will Higher Dupixent Profits Fuel Growth?

A Look At The Fair Value Of Vertex, Inc. (NASDAQ:VERX)

Simply Wall St.

2 months ago

A Look At The Fair Value Of Vertex, Inc. (NASDAQ:VERX)

Share on Social Networks: